BBA
NEXI

Baader Bank Aktiengesellschaft’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-690
Closed -$3.23K – 403
2023
Q3 		$3.23K Buy
690
+55
+9% +$341 ﹤0.01% 306
2023
Q2 		$3.44K Sell
635
-551
-46% -$4.75K ﹤0.01% 392
2023
Q1 		$8.79K Buy
+1,186
New +$12.5K ﹤0.01% 352

Other funds holding NEXI

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baader Bank Aktiengesellschaft's NEXI Position: Q4 2023 in Review

Baader Bank Aktiengesellschaft sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 690 shares — an estimated $3.23K sold.

Baader Bank Aktiengesellschaft first reported a position in NEXI in Q1 2023 and held it in 3 quarters. The position peaked at $8.79K in Q1 2023. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

  • Baader Bank Aktiengesellschaft reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 690 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $3.23K.
  • Baader Bank Aktiengesellschaft first reported a position in NexImmune, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Baader Bank Aktiengesellschaft's NexImmune, Inc. Common Stock position peaked at $8.79K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2023, filed 8 Feb 2024.